MUSTANG BIO, INC. (MBIO): M&A transaction — Mustang Bio repurchases previously sold assets for $1.4M; shareholders approve reverse split and warrant share issuance

MUSTANG BIO, INC.

Company to repurchase assets from uBriGene for $1,395,138; $100K upfront, $1,295,138 deferred for 12 months with possible extensions.
Shareholders approved issuance of up to 60,731,608 shares underlying warrants, representing over 20% of outstanding common stock.
Shareholders also authorized a reverse stock split between 1-for-10 and 1-for-50, with Board to determine exact ratio.
Repurchase is an Expedited Divestment under CFIUS National Security Agreement signed May 13, 2024, reversing the prior sale.
Company may defer deferred payment if net assets fall below $20M; unpaid amounts accrue 5% interest after 12 months.

item 1.01 item 1.02 item 2.01 item 5.07 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

MUSTANG BIO, INC. completed an acquisition involving uBriGene (Boston) Biosciences, Inc. for $1,395,138 (closed 2024-06-27).

Action: acquisition
Counterparty: uBriGene (Boston) Biosciences, Inc.
Consideration: $1,395,138
Closing: 2024-06-27

Exact text from the filing

pursuant to the NSA with CFIUS. As consideration for the Repurchase Transaction, the Company has agreed to pay to uBriGene a total purchase price (the “Purchase Price”) of $1,395,138, consisting of (i) an upfront payment of $100,000 due within five (5) business days of the Effective Date and a (ii) subsequent amount of $1,295,138 due on the date that is twelve

View on SEC.gov

Browse all m&a transactions →

MUSTANG BIO, INC. filing history →

Source: SEC EDGAR

accession 0001104659-24-077596

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.